Identifying gnostic predictors of the vaccine response

Current Opinion in Immunology

Volumn 24, Issue 3, 2012, Pages 332-336

  Haining, W Nicholas ^a,b   Pulendran, Bali ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; TOLL LIKE RECEPTOR; VACCINE;

ALGORITHM; ANTIBODY RESPONSE; ANTIBODY TITER; GENE EXPRESSION PROFILING; GENOMICS; IMMUNE RESPONSE; MATHEMATICAL MODEL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PROGNOSIS; REVIEW; UPREGULATION;

ANIMALS; DRUG DESIGN; GENE EXPRESSION; GENOMICS; HUMANS; VACCINES;

EID: 84862683516     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.03.010     Document Type: Review

References (34)

1. Rappuoli R., Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 2011, 473:463-469.
2. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17:1055-1065.
3. Pulendran B., Li S., Nakaya H.I. Systems vaccinology. Immunity 2010, 33:516-529.
4. Pulendran B., Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011, 131:509-517.
5. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., Pirani A., Gernert K., Deng J., Marzolf B., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10:116-125.
6. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., Means A.R., Kasturi S.P., Khan N., Li G-M., et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011, 12:786-795.
7. Gaucher D., Therrien R., Kettaf N., Angermann B., Boucher G., Filali-Mouhim A., Moser J., Mehta R., Drake D., Castro E., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008, 10.1084/jem.20082292.
8. Allantaz F., Chaussabel D., Stichweh D., Bennett L., Allman W., Mejias A., Ardura M., Chung W., Wise C., Palucka K., et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 2007, 204:2131-2144.
9. Ramilo O., Allman W., Chung W., Mejias A., Ardura M., Glaser C., Wittkowski K.M., Piqueras B., Banchereau J., Palucka A.K., et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007, 109:2066-2077.
10. Chaussabel D., Quinn C., Shen J., Patel P., Glaser C., Baldwin N., Stichweh D., Blankenship D., Li L., Munagala I., et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008, 29:150-164.
11. Berry M.P.R., Graham C.M., McNab F.W., Xu Z., Bloch S.A.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
12. Shi L., Campbell G., Jones W.D., Campagne F., Wen Z., Walker S.J., Su Z., Chu T.-M., Goodsaid F.M., Pusztai L., et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010, 28:827-838.
13. Simon R. Using DNA microarrays for diagnostic and prognostic prediction. Expert Rev Mol Diagn 2003, 3:587-595.
14. Dupuy A., Simon R. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 2007, 99:147-157.
15. Chang H.Y., Sneddon J.B., Alizadeh A.A., Sood R., West R.B., Montgomery K., Chi J.-T., van de Rijn M., Botstein D., Brown P.O. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004, 2:E7.
16. Chi J.-T., Wang Z., Nuyten D.S.A., Rodriguez E.H., Schaner M.E., Salim A., Wang Y., Kristensen G.B., Helland A., Børresen-Dale A-L., et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006, 3:e47.
17. Liu R., Wang X., Chen G.Y., Dalerba P., Gurney A., Hoey T., Sherlock G., Lewicki J., Shedden K., Clarke M.F. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007, 356:217-226.
18. Massague J. Sorting out breast-cancer gene signatures. N Engl J Med 2007, 356:294-297.
19. Mosley J.D., Keri R.A. Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Med Genomics 2008, 1:11.
20. Haining W.N., Wherry E.J. Integrating genomic signatures for immunologic discovery. Immunity 2010, 32:152-161.
21. Subramanian A., Tamayo P., Mootha V., Mukherjee S., Ebert B.L., Gillette M., Paulovich A., Pomeroy S., Golub T.R., Lander E., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550.
22. Tilford C.A., Siemers N.O. Gene set enrichment analysis. Methods Mol Biol 2009, 563:99-121.
23. Ashburner M., Ball C., Blake J., Botstein D., Butler H., Cherry J., Davis A., Dolinski K., Dwight S., Eppig J., et al. Gene Ontology: tool for the unification of biology. Nat Genet 2000, 25:25-29.
24. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 1999, 27:29-34.
25. Liberzon A., Subramanian A., Pinchback R., Thorvaldsdóttir H., Tamayo P., Mesirov J.P. Molecular Signatures Database (MSigDB) 3.0. Bioinformatics 2011, 10.1093/bioinformatics/btr260.
26. Tamayo P., Cho Y.-J., Tsherniak A., Greulich H., Ambrogio L., Schouten-van Meeteren N., Zhou T., Buxton A., Kool M., Meyerson M., et al. Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. J Clin Oncol 2011, 29:1415-1423.
27. Lee E., Chuang H.-Y., Kim J.-W., Ideker T., Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol 2008, 4:e1000217.
28. Shen-Orr S.S., Tibshirani R., Khatri P., Bodian D.L., Staedtler F., Perry N.M., Hastie T., Sarwal M.M., Davis M.M., Butte A.J. Cell type-specific gene expression differences in complex tissues. Nat Methods 2010, 7:287-289.
29. Boehm J.S., Hahn W.C. Towards systematic functional characterization of cancer genomes. Nat Rev Genet 2011, 12:487-498.
30. Yang X., Boehm J.S., Yang X., Salehi-Ashtiani K., Hao T., Shen Y., Lubonja R., Thomas S.R., Alkan O., Bhimdi T., et al. A public genome-scale lentiviral expression library of human ORFs. Nat Methods 2011, 10.1038/nmeth.1638.
31. Amit I., Garber M., Chevrier N., Leite A.P., Donner Y., Eisenhaure T., Guttman M., Grenier J.K., Li W., Zuk O., et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 2009, 326:257-263.
32. Chevrier N., Mertins P., Artyomov M.N., Shalek A.K., Iannacone M., Ciaccio M.F., Gat-Viks I., Tonti E., DeGrace M.M., Clauser K.R., et al. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 2011, 147:853-867.
33. Amit I., Regev A., Hacohen N. Strategies to discover regulatory circuits of the mammalian immune system. Nat Rev Immunol 2011, 11:873-880.
34. Brenner S. Sequences and consequences. Philos Trans R Soc Lond B Biol Sci 2010, 365:207-212.